CVE-2018-14786
7.5 High
CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:L/Au:N/C:P/I:P/A:P
9.4 High
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
LOW
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
9.4 High
AI Score
Confidence
High
0.01 Low
EPSS
Percentile
83.4%
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.
Affected configurations
| CPE | Name | Operator | Version |
|---|---|---|---|
| bd:alaris_gs_firmware | bd alaris gs firmware | le | 2.3.6 |
CNA Affected
[
{
"product": "Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA",
"vendor": "Becton, Dickinson and Company",
"versions": [
{
"status": "affected",
"version": "Version 2.3.6 and prior"
}
]
}
]Related
7.5 High
CVSS2
Attack Vector
NETWORK
Attack Complexity
LOW
Authentication
NONE
Confidentiality Impact
PARTIAL
Integrity Impact
PARTIAL
Availability Impact
PARTIAL
AV:N/AC:L/Au:N/C:P/I:P/A:P
9.4 High
CVSS3
Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
NONE
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
LOW
Integrity Impact
HIGH
Availability Impact
HIGH
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H
9.4 High
AI Score
Confidence
High
0.01 Low
EPSS
Percentile
83.4%